ClinicalTrials.gg
CompletedNCT07388186Updated Oct 16, 2026

Benefits of Strength Training in Informal Caregivers of Patients With Alzheimer's Disease

An interventional study of Progressive Muscle Relaxation and Functional Strength Training in Frailty, Caregiver Burden and Anxiety, sponsored by University of Salamanca. Completed at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by University of Salamanca · Not applicable, Interventional, and Treatment

How we know

Updated Oct 16, 2026Now CompletedStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
43
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 132 studies in Frailty with a site in Spain — 46 open to participants now, 54 under way, none of them phase 3. Frailty · Spain.

Enrollment
76th of 96
43 · median 90
Started
2026
with 20 others
No phase
93 of 132
34 open now
Registered
109th of 132
by date
Lead sponsor
4 of 132
University of Salamanca

Among the 132 studies in Frailty with a site in Spain, this one is the 76th largest by enrollment of the 96 interventional ones that give a count, is one of 21 that started in 2026, is one of 93 with no phase, and was the 109th registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

46 of the 132 studies in Frailty with a site in Spain are open now. Recruiting first, the newest first:

41 more — sign in →

All 46 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 132 studies in Frailty with a site in Spain, or all of them as a file.
02

Study summary

Informal caregivers of people with Alzheimer's disease experience high physical and psychological burden, increasing their risk of frailty, anxiety, and caregiver burnout. This randomized controlled trial aims to evaluate the effectiveness of a combined strength training and progressive muscle relaxation program compared with progressive muscle relaxation alone. The intervention will last 10 weeks, with assessments conducted at baseline, post-intervention, and at a 3-month follow-up. Primary outcomes include frailty, anxiety, and caregiver burden.

Read the detailed description

Alzheimer's disease is associated with long-term caregiving demands that expose informal caregivers to sustained physical and psychological stress. This chronic exposure may contribute to functional decline, increased vulnerability to frailty, and reduced overall well-being, highlighting the need for accessible, non-pharmacological interventions targeting caregiver health.

The present study adopts a parallel-group randomized controlled design in which participants are allocated to one of two intervention arms. One group will participate in structured progressive muscle relaxation sessions, while the other will receive a combined intervention integrating functional strength training with progressive muscle relaxation. The intervention protocol has been designed to be feasible, low-cost, and easily implementable in community and clinical settings.

Assessments will be conducted at multiple time points to examine changes in physical performance and psychological status over time. Standardized performance-based measures and validated self-report instruments will be used to capture functional and psychosocial outcomes, allowing for a comprehensive evaluation of the intervention effects across short- and medium-term follow-up periods.

03

Conditions studied

  • Frailty
  • Caregiver Burden
  • Anxiety

Keywords

  • Frailty
  • Strength
  • Caregiver
  • Anxiety
  • Burden
  • Alzheimer disease
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older
  • Informal caregivers of a person with Alzheimer's disease
  • Providing regular care for at least 10 hours per week
  • Ability to attend intervention sessions
  • Ability to understand and follow instructions
  • Provision of written

Exclusion criteria

Exclusion Criteria:

  • Acute illness or medical conditions contraindicating participation in strength exercise
  • Participation in structured exercise programs that may interfere with study outcomes
  • Severe or uncontrolled psychiatric disorders
  • Physical limitations preventing completion of functional assessments
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
43 participants (actual)

Study arms

  • Active comparator
    Progressive Muscle Relaxation

    Participants in this arm will receive one weekly session of progressive muscle relaxation over a 10-week period. Each session will last approximately 45 minutes and will include diaphragmatic breathing, Jacobson's progressive muscle relaxation technique, controlled breathing exercises, and a brief cooldown period. Sessions will be supervised by a trained physiotherapist.

    Behavioral: Progressive Muscle Relaxation

  • Experimental
    Strength Training plus Progressive Muscle Relaxation

    Participants in this arm will receive a combined intervention consisting of one weekly session of progressive muscle relaxation and one weekly session of functional strength training over a 10-week period. Strength training sessions will focus on upper limb, lower limb, and core muscle groups using progressive resistance. Each session will last approximately 45 minutes and will be supervised by a trained physiotherapist.

    Behavioral: Progressive Muscle Relaxation · Behavioral: Functional Strength Training

Interventions

  • BehavioralProgressive Muscle Relaxation

    Progressive muscle relaxation will be delivered in weekly supervised sessions over a 10-week period. Each session will last approximately 45 minutes and will include diaphragmatic breathing, systematic muscle contraction and relaxation following Jacobson's technique, controlled breathing exercises, and a brief cooldown period. The intervention will be administered by a trained physiotherapist in a group setting.

  • BehavioralFunctional Strength Training

    Functional strength training will be delivered in weekly supervised sessions over a 10-week period. Sessions will last approximately 45 minutes and will focus on improving upper limb, lower limb, and core muscle strength using progressive resistance exercises. Training intensity will be gradually increased according to participant tolerance and performance. All sessions will be supervised by a trained physiotherapist.

06

What researchers measure

Primary outcomes

  1. Frailty

    Frailty will be assessed using the Short Physical Performance Battery (SPPB) and handgrip strength measured with a hand dynamometer. The SPPB includes balance, gait speed, and lower-limb strength components. The score is obtained by summing the results of three performance-based tests: balance, gait speed over 4 meters, and the five-times sit-to-stand chair test. The total score ranges from 0 to 12 points, where 0 represents the worst performance and 12 the best performance. Lower scores (generally \<10) indicate frailty and increased risk of falls. Performance is classified as follows: 0-3 (disabled), 4-6 (frail), 7-9 (prefrail), and 10-12 (independent). Handgrip strength will be measured using a hand dynamometer, and the absolute grip strength value will be recorded. The Fried frailty phenotype includes handgrip strength (dynamometry) as one of the five key criteria for identifying frailty in older adults. Cut-off values indicative of muscle weakness, adjusted for sex and body mass

    Time frame: Baseline, 3-month follow-up and immediately after completion of the intervention (at 10 weeks).

Secondary outcomes

  1. Anxiety

    Anxiety symptoms will be assessed using the Hamilton Anxiety Rating Scale (HAM-A), a validated clinician-rated questionnaire evaluating psychological and somatic anxiety symptoms. HAM-A is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0-56, where \<17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe.

    Time frame: Baseline, 3-month follow-up and immediately after completion of the intervention (at 10 weeks)

  2. Caregiver burden

    Caregiver burden will be assessed using the Zarit Burden Interview (ZBI), a validated self-report questionnaire measuring perceived burden in informal caregivers. The total score is calculated as the sum of all items, with a possible range from 22 to 110. Each item is rated using a 5-point Likert-type scale, with response options ranging from "never" to "almost always", scored from 1 to 5.

    Time frame: Baseline, 3-month follow-up and immediately after completion of the intervention (at 10 weeks)

Other outcomes

  1. Adherence to the intervention

    Adherence will be assessed by recording the number of sessions attended and the percentage of completed sessions for each participant.

    Time frame: Throughout the 10-week intervention period

  2. Adverse events

    Adverse events or incidents occurring during the intervention sessions, such as musculoskeletal discomfort, dizziness, or other exercise-related events, will be recorded and monitored.

    Time frame: Throughout the 10-week intervention period

07

Study locations

1 site
  • Universidad de Salamanca
    Salamanca, 37007, Spain
08

References and documents

Publications

  • Sanchez-Gil A, Sanchez-Gonzalez JL, Gomez-Mateos M, Santos-Rodriguez V, Garcia-Santelesforo R, Perez J, Perez-Robledo F, Perez-Saez E, Calleja-Caballero A. Combined functional strength training and progressive muscle relaxation in informal caregivers of people with dementia: protocol for a randomized controlled trial. Front Psychol. 2026 Sep 17;17:1944170. doi: 10.3389/fpsyg.2026.1944170. eCollection 2026. PubMed 42824482 ↗

Individual participant data

Plan to share: No — De-identified individual participant data will not be shared outside the study team due to ethical, privacy, and data protection considerations.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in Sep 2026, 5 months.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's 5 months is below that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 16, 2026: start Mar 2026 → Apr 2026, primary completion Jul 2026 → Sep 2026 and completion Sep 2026 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 22, 2026
First posted
Feb 4, 2026
StartActual
Apr 10, 2026was Mar 2026
Primary completionActual
Sep 28, 2026was Jul 2026
CompletionActual
Oct 10, 2026was Sep 2026
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Oct 16, 2026
Start date
Mar 2026→Apr 10, 2026 (actual)
Oct 16, 2026
Primary completion
Jul 2026→Sep 28, 2026 (actual)
Oct 16, 2026
Study completion
Sep 2026→Oct 10, 2026 (actual)
Oct 16, 2026
Enrollment
62 (estimated)→43 (actual)
Oct 16, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 42824482 ↗
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    Not yet recruiting→Completed
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 42824482 ↗
    Start date Mar 2026→Apr 10, 2026 (now actual)
    Primary completion Jul 2026→Sep 28, 2026 (now actual)
    Study completion Sep 2026→Oct 10, 2026 (now actual)
    Enrollment 62 (estimated)→43 (actual)
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07388186
Collaborators
Colegio Profesional de Fisioterapeutas de Castilla y León, CRE Alzheimer del Imserso
Responsible party
Andrea Calleja Caballero (Physical therapist, University of Salamanca) — Principal investigator
First posted
Feb 4, 2026
Start date
Apr 10, 2026
Primary completion
Sep 28, 2026
Completion
Oct 10, 2026
Last update
Oct 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion